Published by Global Data on 23rd October 2018 | Ref: 1085933 | This Report Is In Stock
Agile Therapeutics Inc (Agile) is a healthcare company that develops and commercializes prescription contraceptive products for women. The company provides contraceptive patch containing the active ingredients levonorgestrel and ethinyl estradiol and progestin-only birth control patch. Its pipeline product candidate include AG200-15, a once-weekly prescription contraceptive patch designed using its skinfusion technology to deliver both hormones over a seven-day period. The company’s other hormonal contraceptive pipeline include AG200-SP, a novel regimen designed to allow women to experience shorter, lighter periods; AG200-ER, an extended cycle regimen that allows a woman to extend the time between her episodes of withdrawal bleeding. Agile is headquartered in Princeton, New Jersey, the US.
Agile Therapeutics Inc (AGRX) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Agile Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Agile Therapeutics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Agile Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Agile Therapeutics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Agile Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Agile Therapeutics Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Agile Therapeutics Raises USD3 Million in Venture Financing 10
Equity Offering 11
Agile Therapeutics Prices Public Offering of Shares for USD20 Million 11
Agile Therapeutics Raises USD40.3 Million in Public Offering of Shares 13
Agile Therapeutics Inc - Key Competitors 15
Agile Therapeutics Inc - Key Employees 16
Agile Therapeutics Inc - Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Financial Announcements 18
Aug 03, 2018: Agile Therapeutics reports second quarter 2018 financial results 18
May 07, 2018: Agile Therapeutics Announces First Quarter 2018 Financial Results 20
Mar 12, 2018: Agile Therapeutics Announces Fourth Quarter and Full Year 2017 Financial Results 21
Nov 06, 2017: Agile Therapeutics Reports Third Quarter 2017 Financial Results 22
Jul 28, 2017: Agile Therapeutics Reports Second Quarter 2017 Financial Results 24
May 08, 2017: Agile Therapeutics Reports First Quarter 2017 Financial Results 26
Mar 08, 2017: Agile Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results 28
Other Significant Developments 30
Jun 07, 2018: Agile Therapeutics Provides Corporate Update and Revised Cash Guidance 30
About GlobalData 31
Contact Us 31
1085933 | GDME139211D
Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.
Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.
Buy now using our secure payment system.